Cancer Cachexia Market To Generate Revenue Of 4,034 million by 2032 | CAGR of 4.8%
07 mars 2023 02h22 HE | Market.Us
New York, March 07, 2023 (GLOBE NEWSWIRE) -- The global cancer cachexia market accounted for USD 2,554 million in 2022. The cancer cachexia market is set for rapid growth and expected to reach USD...
Cancer Support Commu
Cancer Support Community Releases Report on Cancer Cachexia
12 oct. 2022 13h20 HE | Cancer Support Community
WASHINGTON, D.C., Oct. 12, 2022 (GLOBE NEWSWIRE) -- The Cancer Support Community (CSC) released their Cancer Cachexia Voice of the Patient Report as a follow-up to their Externally-Led Patient...
Cancer Cachexia Market to Reach USD 2.93 Billion by 2027; Rapid Inclination towards Combination Therapies to Aid Growth: Fortune Business Insights™
10 juil. 2020 11h26 HE | Fortune Business Insights
Pune, July 10, 2020 (GLOBE NEWSWIRE) -- The global cancer cachexia market is anticipated to gain traction from the rising shift of the healthcare providers towards combination therapies. Such...
DBMR Logo.png
Cancer Cachexia Market to Reflect a Holistic Expansion During 2026 – Top Companies like Bristol-Myers Squibb Co., XBiotech Inc., Marsala Biotech Inc., Inovio Pharmaceuticals, Inc., Inc., Astellas Pharma Inc. and Others
10 oct. 2019 13h18 HE | Data Bridge Market Research
ROCHESTER, N.Y., Oct. 10, 2019 (GLOBE NEWSWIRE) -- The latest Cancer Cachexia Market report which has been released by Data Bridge Market research highlights the present Chemical and Materials...